Group B Streptococcal (GBS) meningitis

Eval("SummaryImage") Eval("ShowSubscribeCard")
[Error loading the WebPart 'MRF_NewsletterSignUpCard' of type 'MRF-NewsletterSignUpCard']

This form of meningitis is caused by Group B Streptococcal bacteria: Streptococcus agalactiae. 

GBS is the biggest cause of neonatal meningitis (meningitis in newborn babies) in the UK and Ireland, and can also cause septicaemia (blood poisoning) and pneumonia.

The bacteria normally live in the bowels and the vagina and sometimes in the back of the nose and throat.  The bacteria can be transmitted from mother to baby before or during birth.    An estimated 20 –30 %1 of pregnant women carry the bacteria but 99%1 of babies born to mothers who carry the bacteria are perfectly healthy.

A study, supported by Meningitis Research Foundation, found that the incidence of Group B streptococcal infection in newborns in the UK and Ireland is around 7 cases per 10 000 live births (although this figure varies from country to country; 9 cases per 10,000 live births in Northern Ireland to 6 cases per live births in Republic of Ireland to 4 cases per 10,000 live births in Scotland). 

There are two forms:

  • early onset is normally septicaemia, causing shock and breathing difficulty and occurs at birth or within the first  six2 days of life.  The baby catches the bacteria from the birth canal during labour.  Approximately 60 - 70 % of GBS infection is early onset1.
  • late onset is normally meningitis and causes fever, breathing difficulty, feeding problems and fits.  It occurs in the first 7 – 902 days of life and is probably transmitted when babies are in contact with hands contaminated by the bacteria.

GBS pneumonia can be early or late in onset. 

GBS disease can occur in mothers before or after giving birth but this is less common than in babies.  Infection in adults is rare although studies in recent years have shown a slight increase3.  People with immune problems are at a slightly increased risk from GBS infection.

Mothers of babies affected sometimes feel distressed that they may have been the source of infection.  It is important to remember that GBS bacteria are just one of many types of bacteria which naturally live in our bodies, and most babies are not affected by them.

Though the bacteria can be passed on, a person with GBS infection does not pose a risk to others in the community.

Although most babies who get this disease survive with no severe problems, it is a serious illness.  Nearly 10 % of babies2 affected do not survive, and those who recover may have after effects such as deafness, brain damage and problems with movement and co-ordination.  The fatality rate is higher in premature babies. 

Antibiotics can be given to women during labour or to babies after birth to kill the bacteria.  These women can be identified by bacteriological screening, involving taking swabs from the vagina and rectum, or by risk-factor based screening. Risk factors for GBS infection may include having a previous baby with GBS, premature delivery, prolonged rupture of membranes, or when the mother herself is feverish during delivery, or ill with GBS.      

The study mentioned above contributed to UK guidelines developed by the Royal College of Obstetricians and Gynaecologists (RCOG)4.  In Ireland each hospital has its own protocol on GBS, and these are generally similar to the RCOG guidelines.  Screening for GBS is not routinely done in Ireland or the UK.

Immunisation of mothers could also prevent GBS, and several potential vaccines are in development.

  1. Heath P & Feldman RG. Vaccination against Group B streptococcus. Expert Review Vaccines 2005 (2):207-18 15889994&query_hl=1
  2. Heath P et al. Group B streptococcal disease in UK and Irish infants younger than 90 days. Lancet 2004; 363: 292 – 294 14751704&query_hl=5 © Meningitis Research Foundation April 2012
  3. Keshishian C, Lamagni TL, Nunn S & Efstratiou A. The changing epidemiology of invasive group B streptococcal disease in England & Wales, 1990 – 2003. Health Protection Agency Annual Conference 12 – 14th September, 2004; Oral 182
  4. Prevention of early onset neonatal group B streptococcal disease. Royal College of Obstetricians and Gynaecologists November 2003; Guideline No. 36
Jane Plumb, Chief Executive, Group B Strep Support talks about the long-term affects of GBS at MRF's 2017 conference​
Meningitis and septicaemia can kill in hours - know the symptoms.
Group B Streptococcus (GBS) is the leading cause of bacterial meningitis in newborn babies. The GBS3 trial hopes to help combat this infection.
Dr Fiona McGill answers one of our most frequently asked questions.
Connect families affected by meningitis so they don’t feel alone
Connect families affected by meningitis so they don’t feel alone
£58 funds one support worker to attend our ‘Meningitis Meet-Ups’ – a chance for families affected by meningitis to meet each other for informal peer support.
Share this
Membership and support

The MRF Membership and Support team are here for you for any questions you might have about meningitis and septicaemia and their effects on you, or your family and friends.

Tel: Helpline UK 080 8800 3344 Ireland 1800 41 33 44